GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19‐TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schuster, SJ
  • Bishop, MR
  • Tam, C
  • Waller, EK
  • Borchmann, P
  • Mcguirk, J
  • Jäger, U
  • Jaglowski, S
  • Andreadis, C
  • Westin, J
  • Fleury, I
  • Bachanova, V
  • Foley, Ronan
  • Ho, PJ
  • Mielke, S
  • Holte, H
  • Anak, O
  • Pacaud, L
  • Awasthi, R
  • Tai, F
  • Salles, G
  • Maziarz, R

publication date

  • June 2017